Rosario Di Maggio - Concepedia

Author

Rosario Di Maggio

Ospedale Vincenzo Cervello ORCID

Also Known As

R. Di Maggio, R. Maggio, Rosario DI Maggio, Rosario Di Maggio, Rosario di Maggio

Publications

401

Citations

H-Index

Concepts

All Affiliations

Ospedale Vincenzo Cervello Ospedale Microcitemico Ospedali Riuniti Umberto I Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele Ospedale Antonio Cardarelli

About

Rosario Di Maggio is an author at Ospedale Vincenzo Cervello specializing in medicine, hematology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	157
2	Education	1	1	56
3	Critical Care Medicine	1	1	56
4	Pathology	1	1	20
5	Pharmacology	1	1	20

Rosario Di Maggio

Publications

248

Citations

H-Index

Page 1

	Year	Citations
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy? Angela Vitrano, Giuseppina Calvaruso, Eliana Lai, British Journal of Haematology Heart FailureIron MetabolismPrognosisEducationLogistic Analysis	2016	56
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial Farid Boulad, Aurelio Maggio, Xiuyan Wang, Nature Medicine MedicinePhase 1HematologyReduced-intensity Conditioning	2022	45
Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5‐year long‐term <scp>I</scp>talian multicenter randomized clinical trial Giuseppina Calvaruso, Angela Vitrano, Rosario Di Maggio, American Journal of Hematology	2015	44
Long‐term use of deferiprone significantly enhances left‐ventricular ejection function in thalassemia major patients Aurelio Maggio, Angela Vitrano, Gaetano Lucania, American Journal of Hematology Left‐ventricular Ejection FunctionHeart FailureVersus DfpCardiogenic ShockCardiovascular Disease	2012	36
Incidence of cancer and related deaths in hemoglobinopathies: A follow‐up of 4631 patients between 1970 and 2021 Raffaella Origa, Barbara Gianesin, Filomena Longo, Cancer	2022	24
Deferiprone versus Deferoxamine in Sickle Cell Disease: Results from a 5-year long-term Italian multi-center randomized clinical trial Giusi Calvaruso, Angela Vitrano, Rosario Di Maggio, Blood Cells Molecules and Diseases Sickle Cell DiseaseMedicineHematologyPathologyPharmacotherapy	2014	20
Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia Rosario Di Maggio, Matthew M. Hsieh, Xiongce Zhao, International Journal of Molecular Sciences	2018	12
Real‐life experience with liver iron concentration <scp>R</scp>2 <scp>MRI</scp> measurement in patients with hemoglobinopathies: baseline data from <scp>LICNET</scp> Angela Vitrano, Giuseppina Calvaruso, Lorenzo Tesè, European Journal Of Haematology	2016	11

Page 1